BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37746997)

  • 1. Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma.
    Ying J; Hong H; Yu C; Jiang M; Ding D
    Medicine (Baltimore); 2023 Sep; 102(38):e34954. PubMed ID: 37746997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
    Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
    World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHD3 as a Prognosis Marker and its Relationship with Immune Infiltration in Lung Adenocarcinoma.
    Wang L; Zhong Y; Wang G; An H; Gao Q; Ye Y
    Comb Chem High Throughput Screen; 2022; 25(13):2255-2263. PubMed ID: 35088661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma.
    Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S
    J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma.
    Luo L; Su J; Zheng Y; Huang F; Huang R; Luo H
    J Immunol Res; 2021; 2021():9938397. PubMed ID: 34604392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.
    Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B
    World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma.
    Jiang W; Wei Q; Xie H; Wu D; He H; Lv X
    Anal Cell Pathol (Amst); 2023; 2023():4522045. PubMed ID: 37416927
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker.
    Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J
    Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation.
    Zou X; Guo B; Ling Q; Mo Z
    Front Mol Biosci; 2022; 9():832238. PubMed ID: 35127830
    [No Abstract]   [Full Text] [Related]  

  • 16. MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma.
    Hu Y; Liu Y; Ma C; Ai K
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile of Toll‑like receptors in human breast cancer.
    Shi S; Xu C; Fang X; Zhang Y; Li H; Wen W; Yang G
    Mol Med Rep; 2020 Feb; 21(2):786-794. PubMed ID: 31789409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma.
    Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma.
    Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L
    BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
    Nishiya T; DeFranco AL
    J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.